bpc-157 clinical evidence safety and the Difference Between an Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded bpc 157 clinical evidence safety

Crane, R

What we do know from the switching protocols published by various clinical practices is that starting low and titrating up works better than trying to jump to an "equivalent" dose

A person's response to BPC-157 may vary depending on their dosage and the condition they try to treat

Transforming growth factor beta (TGF-): Promotes chondrocyte proliferation and matrix synthesis

The line you cannot cross is selling it or using it on people

That is a bit of a catch-22 because B12 is essential for the intestines to be able to function optimally, but they cannot absorb it (from the food) when they are damaged or diseased